Moyamoya Disease (MMD) and breast cancer due to a BRCA2 germline mutation are both rare diseases, and there are no data in the literature to assess the cumulative incidence ... breast carcinoma in the right breast. The…
Cancer is a dynamic and evolving disease characterized by genetic mutations, alterations in signaling pathways, and interactions with the tumor microenvironment. The progression from a single mutated cell ... into…
produced by using lipid vesicles at pH 7.4. Our findings indicate that single-point mutations affect the aggregation behavior of α-synuclein under the influence of Cardiolipin (CL)-containing vesicles
diagnoses of Pancreatic Ductal Adenocarcinoma (PDAC) and Acute Myeloid Leukemia (AML) with a comprehensive mutational analysis of the pancreatic tumor, AML blasts, and germline DNA collected from cultured skin…
Tumor Mutational Burden (TMB) has emerged as a crucial biomarker in the field of oncology, particularly for predicting patient responses to immune checkpoint inhibitors (ICIs). TMB quantifies the number ... mutations…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.